Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 1
1954 1
1981 1
1982 1
1983 2
1984 5
1985 2
1986 3
1987 2
1988 5
1990 4
1991 2
1992 1
1994 1
1995 2
1996 3
1997 2
1998 2
1999 3
2000 1
2002 4
2003 4
2004 4
2005 4
2006 1
2007 1
2008 1
2009 2
2010 2
2012 2
2013 2
2014 2
2015 3
2016 1
2017 5
2018 4
2022 2
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.
Burgel PR, Sermet-Gaudelus I, Girodon E, Durieu I, Houdouin V, Audousset C, Macey J, Grenet D, Porzio M, Murris-Espin M, Reix P, Baravalle M, Belleguic C, Mely L, Verhille J, Weiss L, Reynaud-Gaubert M, Mittaine M, Hamidfar R, Ramel S, Cosson L, Douvry B, Danner-Boucher I, Foucaud P, Roy C, Burnet E, Raynal C, Audrezet MP, Da Silva J, Martin C; French Cystic Fibrosis Reference Network study group. Burgel PR, et al. Among authors: foucaud p. Lancet Respir Med. 2024 Nov;12(11):888-900. doi: 10.1016/S2213-2600(24)00208-X. Epub 2024 Aug 13. Lancet Respir Med. 2024. PMID: 39151434
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Dreano E, Burgel PR, Hatton A, Bouazza N, Chevalier B, Macey J, Leroy S, Durieu I, Weiss L, Grenet D, Stremler N, Ohlmann C, Reix P, Porzio M, Roux Claude P, Rémus N, Douvry B, Montcouquiol S, Cosson L, Mankikian J, Languepin J, Houdouin V, Le Clainche L, Guillaumot A, Pouradier D, Tissot A, Priou P, Mély L, Chedevergne F, Lebourgeois M, Lebihan J, Martin C, Zavala F, Da Silva J, Lemonnier L, Kelly-Aubert M, Golec A, Foucaud P, Marguet C, Edelman A, Hinzpeter A, de Carli P, Girodon E, Sermet-Gaudelus I, Pranke I; French CF Reference Network study group. Dreano E, et al. Among authors: foucaud p. Eur Respir J. 2023 Oct 19;62(4):2300110. doi: 10.1183/13993003.00110-2023. Print 2023 Oct. Eur Respir J. 2023. PMID: 37696564
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Burgel PR, Sermet-Gaudelus I, Durieu I, Kanaan R, Macey J, Grenet D, Porzio M, Coolen-Allou N, Chiron R, Marguet C, Douvry B, Dufeu N, Danner-Boucher I, Foucaud P, Lemonnier L, Girodon E, Da Silva J, Martin C; French CF Reference Network study group. Burgel PR, et al. Among authors: foucaud p. Eur Respir J. 2023 Feb 16:2202437. doi: 10.1183/13993003.02437-2022. Online ahead of print. Eur Respir J. 2023. PMID: 36796836
[Vivre avec la mucoviscidose].
Foucaud P. Foucaud P. Rev Prat. 2022 Jun;72(6):653-655. Rev Prat. 2022. PMID: 35899672 French. No abstract available.
Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening.
Munck A, Boulkedid R, Weiss L, Foucaud P, Wizla-Derambure N, Reix P, Bremont F, Derelle J, Schroedt J, Alberti C; Gastroenterology and Nutrition Société française de la Mucoviscidose (SFM) Working Group and the ALIMUDE Study Group. Munck A, et al. Among authors: foucaud p. J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):123-130. doi: 10.1097/MPG.0000000000001956. J Pediatr Gastroenterol Nutr. 2018. PMID: 29543697
Children and screens: Groupe de Pédiatrie Générale (Société française de pédiatrie) guidelines for pediatricians and families.
Picherot G, Cheymol J, Assathiany R, Barthet-Derrien MS, Bidet-Emeriau M, Blocquaux S, Carbajal R, Caron FM, Gerard O, Hinterman M, Houde O, Jollivet C, Le Heuzey MF, Mielle A, Ogrizek M, Rocher B, Samson B, Ronziere V, Foucaud P. Picherot G, et al. Among authors: foucaud p. Arch Pediatr. 2018 Feb;25(2):170-174. doi: 10.1016/j.arcped.2017.12.014. Epub 2018 Feb 1. Arch Pediatr. 2018. PMID: 29366533
[Contribution of teledermatology in a hospital pediatrics department].
Nathanson S, Dommergues MA, Hentgen V, Arditty F, Greder Belan A, Carton B, Wozniak C, Parigot J, Foucaud P, Mahé E. Nathanson S, et al. Among authors: foucaud p. Arch Pediatr. 2018 Jan;25(1):13-17. doi: 10.1016/j.arcped.2017.10.027. Epub 2017 Dec 14. Arch Pediatr. 2018. PMID: 29249399 French.
Children and screens: A survey by French pediatricians.
Assathiany R, Guery E, Caron FM, Cheymol J, Picherot G, Foucaud P, Gelbert N; Association française de pédiatrie ambulatoire; Groupe de pédiatrie générale. Assathiany R, et al. Among authors: foucaud p. Arch Pediatr. 2018 Feb;25(2):84-88. doi: 10.1016/j.arcped.2017.11.001. Epub 2017 Dec 12. Arch Pediatr. 2018. PMID: 29246522
[Acute hemorrhagic edema of infancy associated with Coxsackie virus infection].
Debray A, Ollier V, Coutard A, Arditty F, Bekkar S, Bodemer C, Leruez-Ville M, Mirand A, Lesage F, Foucaud P. Debray A, et al. Among authors: foucaud p. Arch Pediatr. 2017 Dec;24(12):1262-1266. doi: 10.1016/j.arcped.2017.09.013. Epub 2017 Nov 22. Arch Pediatr. 2017. PMID: 29174007 French.
89 results